{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:45:19Z","timestamp":1789181119546,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"vor","delay-in-days":513,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM103430"],"award-info":[{"award-number":["P20GM103430"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1074\/jbc.ra118.004682","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T17:58:18Z","timestamp":1548179898000},"page":"5604-5615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface"],"prefix":"10.1016","volume":"294","author":[{"given":"Joseph M.","family":"Schrader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Christopher","family":"Octeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Aballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9575-0407","authenticated-orcid":false,"given":"Dean J.","family":"Kareemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi L.","family":"Camberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-7875","authenticated-orcid":false,"given":"J. Robert","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Kovoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA118.004682_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","article-title":"Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs","volume":"192","author":"Creese","year":"1976","journal-title":"Science"},{"key":"10.1074\/jbc.RA118.004682_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.004682_bib3","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1074\/jbc.RA118.004682_bib4","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1073\/pnas.72.11.4376","article-title":"Brain receptors for antipsychotic drugs and dopamine: direct binding assays","volume":"72","author":"Seeman","year":"1975","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.004682_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med"},{"key":"10.1074\/jbc.RA118.004682_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/cn400121z","article-title":"Classics in chemical neuroscience: clozapine","volume":"4","author":"Wenthur","year":"2013","journal-title":"ACS Chem. Neurosci"},{"key":"10.1074\/jbc.RA118.004682_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3371\/CSRP.6.3.5","article-title":"Clozapine: balancing safety with superior antipsychotic efficacy","volume":"6","author":"Meltzer","year":"2012","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1074\/jbc.RA118.004682_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1021\/cn400189s","article-title":"Clozapine, a fast-off-D2 antipsychotic","volume":"5","author":"Seeman","year":"2014","journal-title":"ACS Chem. Neurosci"},{"key":"10.1074\/jbc.RA118.004682_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/bjp.bp.107.037218","article-title":"CATIE and CUtLASS: can we handle the truth?","volume":"192","author":"Lewis","year":"2008","journal-title":"Br. J. Psychiatry"},{"key":"10.1074\/jbc.RA118.004682_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.4088\/JCP.09com05497yel","article-title":"Clozapine: more side effects but still the best antipsychotic","volume":"71","author":"Kang","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1074\/jbc.RA118.004682_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1074\/jbc.RA118.004682_bib12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1074\/jbc.RA118.004682_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1155\/2013\/645429","article-title":"Parkinson disease psychosis: update","volume":"27","author":"Friedman","year":"2013","journal-title":"Behav. Neurol"},{"key":"10.1074\/jbc.RA118.004682_bib14","series-title":"Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications","first-page":"180","author":"Stahl","year":"2013"},{"key":"10.1074\/jbc.RA118.004682_bib15","first-page":"161","article-title":"Antipsychotic agents differ in how fast they come off the dopamine D2 receptors: implications for atypical antipsychotic action","volume":"25","author":"Kapur","year":"2000","journal-title":"J. Psychiatry Neurosci"},{"key":"10.1074\/jbc.RA118.004682_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41467-017-00716-z","article-title":"Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors","volume":"8","author":"Sykes","year":"2017","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA118.004682_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.euroneuro.2016.01.001","article-title":"The fast-off hypothesis revisited: a functional kinetic study of antipsychotic antagonism of the dopamine D2 receptor","volume":"26","author":"Sahlholm","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1074\/jbc.RA118.004682_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ceb.2013.10.008","article-title":"Recent developments in biased agonism","volume":"27","author":"Wisler","year":"2014","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1074\/jbc.RA118.004682_bib19","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\u201cBreakthrough\u201d dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA118.004682_bib20","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.psychres.2015.02.021","article-title":"Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia","volume":"227","author":"Suzuki","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1074\/jbc.RA118.004682_bib21","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1097\/00004714-198808001-00002","article-title":"Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes","volume":"8","author":"Seeman","year":"1988","journal-title":"J. Clin. Psychopharmacol"},{"key":"10.1074\/jbc.RA118.004682_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s002130000532","article-title":"Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study","volume":"152","author":"Silvestri","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1074\/jbc.RA118.004682_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(91)90386-5","article-title":"Dopamine receptor and adrenoceptor agonists inhibit prolactin release from MMQ cells","volume":"195","author":"Judd","year":"1991","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.RA118.004682_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1677\/jme.0.0140375","article-title":"Absence of D2S dopamine receptor in the prolactin-secreting MMQ pituitary clone: characterization of a wild D2L receptor coupled to native transduction mechanisms","volume":"14","author":"Ventra","year":"1995","journal-title":"J. Mol. Endocrinol"},{"key":"10.1074\/jbc.RA118.004682_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2144\/000113719","article-title":"Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-adenosine A2A receptor complexes in the striatum","volume":"51","author":"Trifilieff","year":"2011","journal-title":"BioTechniques"},{"key":"10.1074\/jbc.RA118.004682_bib26","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/emboj.2008.153","article-title":"Dopamine D2 receptors form higher order oligomers at physiological expression levels","volume":"27","author":"Guo","year":"2008","journal-title":"EMBO J"},{"key":"10.1074\/jbc.RA118.004682_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10842","article-title":"The role of kinetic context in apparent biased agonism at GPCRs","volume":"7","author":"Klein Herenbrink","year":"2016","journal-title":"Nat. Commun"},{"key":"10.1074\/jbc.RA118.004682_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/342926a0","article-title":"Multiple D2 dopamine receptors produced by alternative RNA splicing","volume":"342","author":"Monsma","year":"1989","journal-title":"Nature"},{"key":"10.1074\/jbc.RA118.004682_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nchembio.199","article-title":"Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation","volume":"5","author":"Han","year":"2009","journal-title":"Nat. Chem. Biol"},{"key":"10.1074\/jbc.RA118.004682_bib30","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.bmc.2011.12.019","article-title":"Multi-receptor drug design: haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agents","volume":"20","author":"Peprah","year":"2012","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.RA118.004682_bib31","doi-asserted-by":"crossref","first-page":"29s","DOI":"10.1016\/S0924-9338(00)00526-5","article-title":"The preclinical pharmacologic profile of tiapride","volume":"16","author":"Scatton","year":"2001","journal-title":"Eur. Psychiatry"},{"key":"10.1074\/jbc.RA118.004682_bib32","doi-asserted-by":"crossref","DOI":"10.4161\/cl.29390","article-title":"Current understanding of signal amplification in phototransduction","volume":"4","author":"Arshavsky","year":"2014","journal-title":"Cell. Logist"},{"key":"10.1074\/jbc.RA118.004682_bib33","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Dos Santos Pereira","year":"2014","journal-title":"AAPS J"},{"key":"10.1074\/jbc.RA118.004682_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129394","article-title":"Quantitative measurement of GPCR endocytosis via pulse-chase covalent labeling","volume":"10","author":"Kumagai","year":"2015","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.004682_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1021\/cb800025k","article-title":"HaloTag: a novel protein labeling technology for cell imaging and protein analysis","volume":"3","author":"Los","year":"2008","journal-title":"ACS Chem. Biol"},{"key":"10.1074\/jbc.RA118.004682_bib36","doi-asserted-by":"crossref","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.004682_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.str.2008.05.001","article-title":"A specific cholesterol binding site is established by the 2.8 \u00c5 structure of the human \u03b22-adrenergic receptor","volume":"16","author":"Hanson","year":"2008","journal-title":"Structure"},{"key":"10.1074\/jbc.RA118.004682_bib38","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/j.1600-0854.2012.01401.x","article-title":"Sensitive and high resolution localization and tracking of membrane proteins in live cells with BRET","volume":"13","author":"Lan","year":"2012","journal-title":"Traffic"},{"key":"10.1074\/jbc.RA118.004682_bib39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1600-0854.2009.00932.x","article-title":"Functional rescue of \u03b2-adrenoceptor dimerization and trafficking by pharmacological chaperones","volume":"10","author":"Kobayashi","year":"2009","journal-title":"Traffic"},{"key":"10.1074\/jbc.RA118.004682_bib40","doi-asserted-by":"crossref","first-page":"21285","DOI":"10.1074\/jbc.M701555200","article-title":"D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin","volume":"282","author":"Free","year":"2007","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.004682_bib41","doi-asserted-by":"crossref","first-page":"29819","DOI":"10.1074\/jbc.270.50.29819","article-title":"Differential glycosylation and intracellular trafficking for the long and short isoforms of the D2 dopamine receptor","volume":"270","author":"Fishburn","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.004682_bib42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbamcr.2014.09.024","article-title":"N-Linked glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane","volume":"1853","author":"Min","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA118.004682_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","article-title":"Dopamine receptors: IUPHAR Review 13","volume":"172","author":"Beaulieu","year":"2015","journal-title":"Br. J. Pharmacol"},{"key":"10.1074\/jbc.RA118.004682_bib44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/er.2013-1121","article-title":"Chaperoning G protein-coupled receptors: from cell biology to therapeutics","volume":"35","author":"Tao","year":"2014","journal-title":"Endocr. Rev"},{"key":"10.1074\/jbc.RA118.004682_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/187221411794351851","article-title":"Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors","volume":"5","author":"Ulloa-Aguirre","year":"2011","journal-title":"Recent Pat. Endocr. Metab. Immune Drug Discov"},{"key":"10.1074\/jbc.RA118.004682_bib46","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1523\/JNEUROSCI.2840-04.2005","article-title":"D2 dopamine receptors colocalize regulator of G-protein signaling 9\u20132 (RGS9\u20132) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways","volume":"25","author":"Kovoor","year":"2005","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.RA118.004682_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071152","article-title":"The conserved arginine cluster in the insert of the third cytoplasmic loop of the long form of the D2 dopamine receptor (D2L-R) acts as an intracellular retention signal","volume":"17","author":"Kubale","year":"2016","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.RA118.004682_bib48","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1242\/jcs.114.19.3517","article-title":"Intracellular retention of the two isoforms of the D2 dopamine receptor promotes endoplasmic reticulum disruption","volume":"114","author":"Prou","year":"2001","journal-title":"J. Cell Sci"},{"key":"10.1074\/jbc.RA118.004682_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/MB:34:1:1","article-title":"Molecular characterization of dopamine D2 receptor isoforms tagged with green fluorescent protein","volume":"34","author":"Sedaghat","year":"2006","journal-title":"Mol. Biotechnol"},{"key":"10.1074\/jbc.RA118.004682_bib50","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1074\/jbc.M112.443945","article-title":"Plasma membrane compartmentalization of D2 dopamine receptors","volume":"288","author":"Sharma","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA118.004682_bib51","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1046\/j.1471-4159.2003.01763.x","article-title":"Differential subcellular localization of two dopamine D2 receptor isoforms in transfected NG108\u201315 cells","volume":"85","author":"Takeuchi","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.004682_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2710.1996.tb01143.x","article-title":"Haloperidol blood levels and clinical outcome: a meta-analysis of studies relevant to testing the therapeutic window hypothesis","volume":"21","author":"de Oliveira","year":"1996","journal-title":"J. Clin. Pharm. Ther"},{"key":"10.1074\/jbc.RA118.004682_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-2914-6_8","article-title":"Monitoring G protein activation in cells with BRET","volume":"1335","author":"Masuho","year":"2015","journal-title":"Methods Mol. Biol"},{"key":"10.1074\/jbc.RA118.004682_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105791","article-title":"G protein \u03b25 is targeted to D2-dopamine receptor-containing biochemical compartments and blocks dopamine-dependent receptor internalization","volume":"9","author":"Octeau","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA118.004682_bib55","series-title":"Topics in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7355_2017_14","article-title":"Biased agonist pharmacochaperones: small molecules in the toolbox for selectively modulating GPCR activity","author":"Mouillac","year":"2017"},{"key":"10.1074\/jbc.RA118.004682_bib56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J. Am. Soc. Nephrol"},{"key":"10.1074\/jbc.RA118.004682_bib57","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bmcl.2006.10.036","article-title":"Studies towards the identification of a new generation of atypical antipsychotic agents","volume":"17","author":"Garzya","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1074\/jbc.RA118.004682_bib58","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1471-4159.2011.07559.x","article-title":"D2-dopamine receptors target regulator of G protein signaling 9-2 to detergent-resistant membrane fractions","volume":"120","author":"Celver","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.004682_bib59","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1124\/dmd.113.055095","article-title":"Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake","volume":"42","author":"Boxberger","year":"2014","journal-title":"Drug Metab. Dispos. Biol. Fate Chem"},{"key":"10.1074\/jbc.RA118.004682_bib60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0854.2010.01134.x","article-title":"Reticulon short hairpin transmembrane domains are used to shape ER tubules","volume":"12","author":"Zurek","year":"2011","journal-title":"Traffic"},{"key":"10.1074\/jbc.RA118.004682_bib61","doi-asserted-by":"crossref","first-page":"14349","DOI":"10.1073\/pnas.94.26.14349","article-title":"Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family","volume":"94","author":"Samad","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA118.004682_bib62","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1471-4159.2010.06805.x","article-title":"RGS9\u20132 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors","volume":"114","author":"Celver","year":"2010","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.RA118.004682_bib63","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","article-title":"A practical guide to evaluating colocalization in biological microscopy","volume":"300","author":"Dunn","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820355162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820355162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA118.004682","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T08:16:23Z","timestamp":1639815383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820355162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":63,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0021925820355162"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra118.004682","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734901621.793555693","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA118.004682","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Schrader et al.","name":"copyright","label":"Copyright"}]}}